
Development of innovative pharmaceutical and biotechnology products, focusing on advanced drug delivery systems.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: December 2025
This analysis is not yet available in English. Please see the French version.
A
The organization is among the top 5% of organizations with the most committed CSR communication, among comparable organizations.
Leading organizations
Takeda
B
Development and commercialization of innovative medicines in various therapeutic areas, including gastrointestinal diseases, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines.
Nemera
B
Design and manufacture drug delivery device solutions for pharmaceutical, biotechnology, and generic industries.
Aptar
A
Development of consumer dispensing, drug delivery, and active material science solutions for various industries.
Initiatives identified among leaders
Conception de produits et de processus pour réduire les émissions de gaz à effet de serre
“Aptar conçoit des produits et des processus pour r...” - AptarRéduction des déchets et des émissions de CO2
“Takeda réduit ses déchets et ses émissions de CO2” - TakedaDéveloppement d'une stratégie de durabilité
“Aptar a développé une stratégie de durabilité basé...” - Aptar59% of similar organizations communicate on CSR issues
+2911 initiatives collected from 100 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports